Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 65,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed.
Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans.
With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization.
Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.
Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans.
With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization.
Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.
Location: United States, Tennessee, Franklin
Employees: 11-50
Phone: +1 615-861-2634
Founded date: 2010
Investors 2
| Date | Name | Website |
| - | Nashville ... | nashvillec... |
| - | Sovereigns... | sovereigns... |
Mentions in press and media 9
| Date | Title | Description |
| 17.08.2023 | Medicare beneficiaries deserve access to genetic counselors | Precision medicine driven by genetic health care is knocking on the door. It offers hope that, sooner than later, we can address health problems like Alzheimer’s disease, cancer, and heart disease that affect the lives of so many Americans.... |
| 07.06.2023 | Lyric (formerly ClaimsXten Portfolio) to Add Genetic Testing Edits Module to its Market Leading Payment Accuracy Solutions | Simplifying the business of care. “This partnership is just one example of Lyric’s vision to simplify the business of care. We’ll expand our own expertise and innovation, while creating partnerships that will result in a comprehensive playl... |
| 26.08.2021 | Concert Genetics Launches Genetic Test Payment Accuracy Solution for Medicare and Medicare Advantage | |
| 12.01.2021 | Concert Genetics Launches Preferred Laboratory Network | |
| 31.07.2018 | Who Has Your DNA? Why Data Privacy Is the Next Battleground in Consumer Genetics | Genetics is changing the world as we know it, and not only in the realm of healthcare and medical science. Whether it’s 23andMe delivering specific details about our ancestry, genetic science being used to united people who have been switch... |
| 28.03.2018 | Genetic testing has reached an exciting tipping point, but it’s also the subject of parody | But clearly the real promise of genetic testing is about its use to make better medical decisions and the medical system has had a long road to making that precision medicine promise real. There are numerous reasons for this: early on, the ... |
| 08.01.2018 | Concert Genetics Completes Growth Financing | Concert Genetics, Inc., a Nashville, Tenn.-based provider of the data and digital infrastructure for reliable and efficient management of genetic testing, completed a growth capital financing round with a structured facility led by Deerfiel... |
| 13.12.2017 | GeneMatters: How Genetic Testing Is Pushing Us Toward Medicine’s Next Frontier | Genetic testing has gone mainstream — consider examples like 23andMe and even Ancestry.com, which both offer genetic analysis by mail — and the market is on track to exceed $10 billion in the next several years. Carter Williams, iSelect CEO... |
| - | Genetic testing has reached an exciting tipping point, but it’s also the subject of parody | Since Crick and Watson figured out the structure of DNA in 1953, there has been a constant effort to make genomics meaningful to medicine in a broad scale way. Here we are, a mere 65 years later, and it seems that genomic sequencing has fin... |